PRKAA1 and neoplasm: Taken together, the results suggest that the presence of glycogen in healthy colon epithelia at tumor initiation may inhibit AMPK, whereas upon tumor evolution, combined loss of capacity to store glycogen and increased glucose uptake and metabolism induce a ROS/AMPK/EP300/β-catenin axis that sustains proliferation of colon cancer cells.